Description
A potent HMG-CoA reductase inhibitor (Ki = 2.3 nM for the active, open ring form of the molecule); a ring hydroxylated metabolite of mevastatin; reduces total plasma cholesterol levels by 29% in dogs when administered at 20 mg/kg per day for five weeks
Formal name: (βR,δR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid
Synonyms:
Molecular weight: 424.5
CAS: 81093-37-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cardiovascular System|Cardiovascular Diseases||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Cell Biology|Cell Death|Ferroptosis||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias